There are 807 resources available
Conclusions and perspectives: Current questions and challenges
Presenter: Chiyo Imamura
Session: Sex and gender differences: Why they matter in oncology
Resources:
Slides
Webcast
208MO - Immune related adverse events and biomarkers after Anbal-cel, novel anti-CD19 CAR-T therapy with dual silencing of PD-1 and TIGIT: Updates from phase I study
Presenter: Won Seog Kim
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
209MO - Impact of CMV reactivation on survival and relapse following allogeneic stem cell transplantation for de novo myeloid sarcoma
Presenter: Benjamin McCormick
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 208MO and 209MO
Presenter: Michelle Poon
Session: Mini Oral session: Haematological malignancies
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Michelle Poon
Session: Mini Oral session: Haematological malignancies
Resources:
Slides
Webcast
Biomarkers of response, PFS and OS for targeted and immunotherapy of stage IV melanoma
Presenter: Ben Aissa Assma
Session: Predicting outcomes in melanoma
Resources:
Slides
Webcast
Presentation of case/condition: T2N0M0 TNBC, 35 yo patient who have 5 yo daughter and announced her diagnosis today
Presenter: Shigehira Saji
Session: Diagnosis and treatment decisions for early breast cancer patient with BRCA mutation
Resources:
Slides
Webcast
Management of gliomas in light of WHO 2021 classification: Current approaches and novel therapeutic targets for gliomas
Presenter: Michael Weller
Session: Novel diagnostic and therapeutic approaches to primary brain tumors
Resources:
Slides
Webcast
Oligometastasis: State of the art in 2022
Presenter: Alexander Louie
Session: Recent updates in radiation oncology
Resources:
Slides
Webcast
How to customise adjuvant treatment in melanoma
Presenter: Alexander van Akkooi
Session: Predicting outcomes in melanoma
Resources:
Slides
Webcast